NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

unfortunately by December 2016 we already had the 331 patients with 232 treatment and 99 placebos set in stone.

Yes but nobody knows. The company say that they are blinded.
December 15, 2016= more than 17 months before the publication of the first results on survival from the DCvax-L Pase III trial.

Dr. Liau knew that the randomization of 2.3:1 was permanent.

I don't know if Dr. Linda Liau knew that the randomization was 2,3:1. That is not what she told the public:

Anyway, in December 2016, she could not publicly say that there were 232 patients who got DCvax-L from the start.(IMO) Think about that.